Hepatitis Monthly

Published by: Kowsar

Serum Levels of Interleukin-4, Interleukin-10 and Interferon-γ in Patients with Chronic Hepatitis B Infection

Seyed Hedayat Hosseini Khorami 1 , 2 , Foroogh Nejatollahi 1 , 2 , * and Mohammad Ali Davarpanah 1 , 3
Authors Information
1 Shiraz HIV/AIDS Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2 Recombinant Antibody Laboratory, Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran
3 Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Hepatitis Monthly: April 2018, 18 (4); e60377
  • Published Online: April 30, 2018
  • Article Type: Research Article
  • Received: August 16, 2017
  • Revised: December 25, 2017
  • Accepted: February 19, 2018
  • DOI: 10.5812/hepatmon.60377

To Cite: Hosseini Khorami S H, Nejatollahi F, Davarpanah M A. Serum Levels of Interleukin-4, Interleukin-10 and Interferon-γ in Patients with Chronic Hepatitis B Infection, Hepat Mon. 2018 ;18(4):e60377. doi: 10.5812/hepatmon.60377.

Abstract
Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Kwon SY, Lee CH. Epidemiology and prevention of hepatitis B virus infection. Korean J Hepatol. 2011;17(2):87-95. doi: 10.3350/kjhep.2011.17.2.87. [PubMed: 21757978].
  • 2. Rahimi R, Hosseini SY, Fattahi MR, Sepehrimanesh M, Safarpour A, Malekhosseini SA, et al. YMDD Motif Mutation Profile Among Patients Receiving Liver Transplant Due to Hepatitis B Virus Infection With Long Term Lamivudine/Immunoglobulin Therapy. Hepat Mon. 2015;15(7). e27120. doi: 10.5812/hepatmon.27120v2. [PubMed: 26300928].
  • 3. Alavian SM, Fallahian F, Lankarani KB. The changing epidemiology of viral hepatitis B in Iran. J Gastrointestin Liver Dis. 2007;16(4):403-6. [PubMed: 18193122].
  • 4. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect. 2008;14(9):858-66. doi: 10.1111/j.1469-0691.2008.02053.x. [PubMed: 18844687].
  • 5. Alavian SM, Hajarizadeh B, Ahmadzad-Asl M, Kabir A, Bagheri-Lankarani K. Hepatitis B virus infection in Iran: A systematic review. Hepatitis monthly. 2008;8(4):281-94.
  • 6. Shamsdin SA, Sepehrimanesh M, Pezeshki B, Nejabat M. Seroprevalence of hepatitis B and C in patients with hemophilia: A single-centre descriptive study. Shiraz E Med J. 2015;16(7). doi: 10.17795/semj24573.
  • 7. Ferrari C. HBV and the immune response. Liver Int. 2015;35 Suppl 1:121-8. doi: 10.1111/liv.12749. [PubMed: 25529097].
  • 8. Larrubia JR, Benito-Martinez S, Miquel-Plaza J, Sanz-de-Villalobos E, Gonzalez-Mateos F, Parra T. Cytokines - their pathogenic and therapeutic role in chronic viral hepatitis. Rev Esp Enferm Dig. 2009;101(5):343-51. doi: 10.4321/S1130-01082009000500006. [PubMed: 19527080].
  • 9. Busca A, Kumar A. Innate immune responses in hepatitis B virus (HBV) infection. Virol J. 2014;11:22. doi: 10.1186/1743-422X-11-22. [PubMed: 24507433].
  • 10. Chang ML, Liaw YF, Hadziyannis SJ. Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Aliment Pharmacol Ther. 2015;42(3):243-57. doi: 10.1111/apt.13272. [PubMed: 26151841].
  • 11. Wang L, Zou ZQ, Liu CX, Liu XZ. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review. J Immunol Methods. 2014;407:1-8. doi: 10.1016/j.jim.2014.04.004. [PubMed: 24747918].
  • 12. He D, Li M, Guo S, Zhu P, Huang H, Yan G, et al. Expression pattern of serum cytokines in hepatitis B virus infected patients with persistently normal alanine aminotransferase levels. J Clin Immunol. 2013;33(7):1240-9. doi: 10.1007/s10875-013-9931-0. [PubMed: 23954997].
  • 13. Lian JQ, Yang XF, Zhao RR, Zhao YY, Li Y, Zhang Y, et al. Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection. Hepat Mon. 2014;14(6). e18892. doi: 10.5812/hepatmon.18892. [PubMed: 24976843].
  • 14. Tan AT, Koh S, Goh W, Zhe HY, Gehring AJ, Lim SG, et al. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. J Hepatol. 2010;52(3):330-9. doi: 10.1016/j.jhep.2009.12.015. [PubMed: 20137825].
  • 15. Ku LT, Gercel-Taylor C, Nakajima ST, Taylor DD. Alterations of T cell activation signalling and cytokine production by postmenopausal estrogen levels. Immun Ageing. 2009;6:1. doi: 10.1186/1742-4933-6-1. [PubMed: 19265538].
  • 16. Hyodo N, Tajimi M, Ugajin T, Nakamura I, Imawari M. Frequencies of interferon-gamma and interleukin-10 secreting cells in peripheral blood mononuclear cells and liver infiltrating lymphocytes in chronic hepatitis B virus infection. Hepatol Res. 2003;27(2):109-16. doi: 10.1016/S1386-6346(03)00199-2. [PubMed: 14563424].
  • 17. Poovorawan K, Tangkijvanich P, Chirathaworn C, Wisedopas N, Treeprasertsuk S, Komolmit P, et al. Circulating cytokines and histological liver damage in chronic hepatitis B infection. Hepat Res Treat. 2013;2013:757246. doi: 10.1155/2013/757246. [PubMed: 24288603].
  • 18. El-Kady IM, Lotfy M, Badra G, El-Masry S, Waked I. Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections. Scand J Immunol. 2005;61(1):87-91. doi: 10.1111/j.0300-9475.2005.01529.x. [PubMed: 15644127].
  • 19. Biedermann T, Rocken M, Carballido JM. TH1 and TH2 lymphocyte development and regulation of TH cell-mediated immune responses of the skin. J Investig Dermatol Symp Proc. 2004;9(1):5-14. doi: 10.1111/j.1087-0024.2004.00829.x. [PubMed: 14870978].
  • 20. Sun QL, Ran W. Review of cytokine profiles in patients with hepatitis. World J Gastroenterol. 2004;10(12):1709-15. doi: 10.3748/wjg.v10.i12.1709. [PubMed: 15188491].
  • 21. Monsalve-De Castillo F, Romero TA, Estevez J, Costa LL, Atencio R, Porto L, et al. Concentrations of cytokines, soluble interleukin-2 receptor, and soluble CD30 in sera of patients with hepatitis B virus infection during acute and convalescent phases. Clin Diagn Lab Immunol. 2002;9(6):1372-5. doi: 10.1128/CDLI.9.6.1372-1375.2002. [PubMed: 12414777].
  • 22. Penna A, Del Prete G, Cavalli A, Bertoletti A, D'Elios MM, Sorrentino R, et al. Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology. 1997;25(4):1022-7. doi: 10.1002/hep.510250438. [PubMed: 9096614].
  • 23. Khan S, Bhargava A, Pathak N, Maudar KK, Varshney S, Mishra PK. Circulating Biomarkers and their Possible Role in Pathogenesis of Chronic Hepatitis B and C Viral Infections. Indian J Clin Biochem. 2011;26(2):161-8. doi: 10.1007/s12291-010-0098-7. [PubMed: 22468043].
  • 24. Ozguler M, Akbulut HH, Akbulut A. Evaluation of Interleukin-10 Levels in Patients Diagnosed with Chronic Hepatitis. West Indian Med J. 2015;64(2):71-5. doi: 10.7727/wimj.2014.154. [PubMed: 26360676].
  • 25. Saxena R, Chawla YK, Verma I, Kaur J. Association of interleukin-10 with hepatitis B virus (HBV) mediated disease progression in Indian population. Indian J Med Res. 2014;139(5):737-45. [PubMed: 25027084].
  • 26. Conde SR, Feitosa RN, Freitas FB, Hermes RB, Demachki S, Araujo MT, et al. Association of cytokine gene polymorphisms and serum concentrations with the outcome of chronic hepatitis B. Cytokine. 2013;61(3):940-4. doi: 10.1016/j.cyto.2013.01.004. [PubMed: 23395388].
  • 27. Dimitropoulou D, Karakantza M, Theodorou GL, Leonidou L, Assimakopoulos SF, Mouzaki A, et al. Serum cytokine profile in patients with hepatitis B e antigen-negative chronic active hepatitis B and inactive hepatitis B virus carriers. World J Gastrointest Pathophysiol. 2013;4(1):24-7. doi: 10.4291/wjgp.v4.i1.24. [PubMed: 23596552].
  • 28. Akpolat N, Yahsi S, Godekmerdan A, Demirbag K, Yalniz M. Relationship between serum cytokine levels and histopathological changes of liver in patients with hepatitis B. World J Gastroenterol. 2005;11(21):3260-3. doi: 10.3748/wjg.v11.i21.3260. [PubMed: 15929178].
  • 29. Song le H, Binh VQ, Duy DN, Kun JF, Bock TC, Kremsner PG, et al. Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol. 2003;28(1):93-103. doi: 10.1016/S1386-6532(02)00271-8. [PubMed: 12927756].
  • 30. Jegaskanda S, Ahn SH, Skinner N, Thompson AJ, Ngyuen T, Holmes J, et al. Downregulation of interleukin-18-mediated cell signaling and interferon gamma expression by the hepatitis B virus e antigen. J Virol. 2014;88(18):10412-20. doi: 10.1128/JVI.00111-14. [PubMed: 24872585].
  • 31. Priimägi L, Tefanova V, Tallo T, Schmidt E. The role of serum Th1 and Th2 cytokines in patients with chronic hepatitis B and hepatitis C virus infection. Acta Med Litu. 2005;12(3):28-31.
  • 32. Sofian M, Aghakhani A, Farazi AA, Banifazl M, Eslamifar A, Rashidi N, et al. Serum profile of T helper 1 and T helper 2 cytokines in hepatitis C virus infected patients. Hepat Mon. 2012;12(12). e6156. doi: 10.5812/hepatmon.6156. [PubMed: 23423691].
  • 33. Yalcin K, Degertekin H, Yildiz F, Celik Y. Markers of disease activity in chronic hepatitis B virus infection. Clin Invest Med. 2003;26(1):27-34. [PubMed: 12659467].
  • 34. Mohammadi M, Nejatollahi F. 3D structural modeling of neutralizing scFv against glycoprotein-D of HSV-1 and evaluation of antigen-antibody interactions by bioinformatic methods. Int J Pharm Bio Sci. 2014;5(4):835-47.
  • 35. Moazen B, Ebrahimi E, Nejatollahi F. Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections. Jundishapur J Microbiol. 2016;9(3). e16241. doi: 10.5812/jjm.16241. [PubMed: 27217918].
  • 36. Bagheri V, Nejatollahi F, Esmaeili SA, Momtazi AA, Motamedifar M, Sahebkar A. Neutralizing human recombinant antibodies against herpes simplex virus type 1 glycoproteins B from a phage-displayed scFv antibody library. Life Sci. 2017;169:1-5. doi: 10.1016/j.lfs.2016.11.018. [PubMed: 27888111].
  • 37. Hashimoto M, Im SJ, Araki K, Ahmed R. Cytokine-Mediated Regulation of CD8 T-Cell Responses During Acute and Chronic Viral Infection. Cold Spring Harb Perspect Biol. 2017. doi: 10.1101/cshperspect.a028464. [PubMed: 29101105].
  • 38. Beltra JC, Decaluwe H. Cytokines and persistent viral infections. Cytokine. 2016;82:4-15. doi: 10.1016/j.cyto.2016.02.006. [PubMed: 26907634].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments